Company Filing History:
Years Active: 2006
Title: Alan Rothaul - Innovator in Inflammatory Disorder Treatments
Introduction
Alan Rothaul is a notable inventor based in Essex, GB. He has made significant contributions to the field of medical treatments, particularly focusing on inflammatory and autoimmune diseases. His innovative approach has led to the development of a unique method that utilizes mefloquine for treating these conditions.
Latest Patents
Alan Rothaul holds a patent for the treatment of inflammatory disorders. This patent outlines a method of treating an inflammatory disease or an autoimmune disease in a subject through the administration of mefloquine. This innovative treatment has the potential to improve the quality of life for many individuals suffering from these challenging health issues.
Career Highlights
Throughout his career, Alan has been associated with Arakis Ltd., a company dedicated to advancing pharmaceutical solutions. His work at Arakis Ltd. has allowed him to focus on developing effective treatments that address critical health concerns.
Collaborations
Alan has collaborated with several talented individuals in his field, including Benjamin Mark Skead and Robin Mark Bannister. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Alan Rothaul's contributions to the treatment of inflammatory disorders highlight his dedication to improving healthcare through innovation. His work continues to inspire others in the field of medical research and development.